Clinical Trial Update: Expansion of SCG/GCG-Based CAD Sceering: Inclusion of Healthy Controls and CCTA Patients [NA]

View source ↗

Summary

The trial expanding SCG/GCG-based screening for coronary artery disease now includes healthy controls and CCTA patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Heart Force Medical Inc. | Conditions: Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | NA | Status: COMPLETED